首页> 外国专利> Use of agomelatine in combination with a selective serotonin reuptake inhibitor (IRS) or any other Compound, causing elevation of the extracellular level of SEROTONIA,Useful for preparing medicine to treat Diseases sensitive to the effect of an IRS like Depression, Anxiety Disorders and others.

Use of agomelatine in combination with a selective serotonin reuptake inhibitor (IRS) or any other Compound, causing elevation of the extracellular level of SEROTONIA,Useful for preparing medicine to treat Diseases sensitive to the effect of an IRS like Depression, Anxiety Disorders and others.

机译：阿戈美拉汀与选择性5-羟色胺再摄取抑制剂（IRS）或任何其他化合物的组合使用可引起细胞外血清SEROTONIA水平的升高，可用于制备治疗对IRS敏感的疾病，例如抑郁症，焦虑症等。

页面导航

摘要
著录项
相似文献

摘要

Pharmaceutical composition comprising a compound of agomelatine and serotonin reuptake inhibitor or any other compound that causes an elevation in the level of extracellular serotonin.

机译：药物组合物，其包含阿戈美拉汀和5-羟色胺再摄取抑制剂的化合物或引起细胞外5-羟色胺水平升高的任何其他化合物。

著录项

公开/公告号CL2004001691A1

专利类型
公开/公告日2005-05-27

原文格式PDF
申请/专利权人 H. LUNDBECK A/S;
展开▼

申请/专利号CL20040001691
发明设计人 WILLIGERS SANDRA;
展开▼

申请日2004-07-02
分类号A61K31/135;A61K31/138;A61K31/165;A61K31/343;A61P25/24;
国家 CL
入库时间 2022-08-21 22:18:20

相似文献

专利
外文文献
中文文献